319 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
CLNX | €30.91 | -3.7% | -9.1% | €21.8b | €44.23 | PS5.5x | E64.8% | 0.2% | Telecom | ||
MRO | UK£6.26 | -0.4% | 1.8% | UK£8.0b | UK£6.55 | PS2.3x | E100.9% | 0.9% | Capital Goods | ||
ORSTED | DKK 302.40 | 1.7% | -21.5% | DKK 127.1b | DKK 369.76 | PS1.8x | E31.2% | 0% | Utilities | ||
APG | US$40.88 | 9.1% | 16.4% | US$11.2b | US$43.90 | PS1.6x | E94.4% | n/a | Capital Goods | ||
FLUT New | US$287.74 | 2.0% | 36.4% | US$51.8b | US$310.73 | PS3.8x | E62.8% | 0% | Consumer Services | ||
COHR | US$86.24 | -0.3% | 42.6% | US$13.4b | US$116.25 | PS2.5x | E88.4% | n/a | Tech | ||
DKNG | US$49.44 | 6.4% | 21.1% | US$24.9b | US$57.29 | PS5.1x | E50.4% | n/a | Consumer Services | ||
GALD | CHF 113.76 | -0.3% | n/a | CHF 27.0b | CHF 107.26 | PS7x | E36.6% | n/a | Pharmaceuticals & Biotech | ||
NPN | R4,861.86 | 13.3% | 45.6% | R806.4b | R5,709.04 | PE12.7x | E19.8% | 0.2% | Retail | ||
DLTR | US$76.29 | 5.9% | -47.3% | US$16.3b | US$84.09 | PS0.5x | E33.2% | n/a | Consumer Retailing | ||
1COV | €58.70 | 0.9% | 17.8% | €11.1b | €61.82 | PS0.8x | E62.4% | 0% | Materials | ||
A035720 | ₩39,950.00 | 3.1% | -30.0% | ₩17.5t | ₩46,671.43 | PS2.2x | E63.2% | 0.2% | Media | ||
000002 | CN¥7.62 | -2.4% | -25.3% | CN¥84.4b | CN¥7.43 | PS0.2x | E88.5% | 0% | Real Estate Management and Development | ||
MTZ New | US$132.77 | -3.1% | 83.9% | US$10.5b | US$162.54 | PE116.5x | E36.2% | n/a | Capital Goods | ||
2002 | NT$23.00 | -1.1% | -8.0% | NT$345.4b | NT$24.13 | PE89.8x | E62.2% | 1.5% | Materials | ||
UN0 | €43.96 | -1.4% | -22.2% | €18.3b | €34.83 | PS0.2x | E58.7% | 0% | Utilities | ||
TECK.B New | CA$61.46 | -1.2% | 17.9% | CA$31.1b | CA$70.57 | PS3.5x | E58.9% | 1.6% | Materials | ||
ILMN | US$97.20 | -3.0% | -26.9% | US$15.4b | US$146.76 | PS3.5x | E56.7% | 3.2% | Pharmaceuticals & Biotech | ||
GMED | US$84.12 | -0.01% | 52.2% | US$11.5b | US$97.85 | PE125.2x | E49.1% | n/a | Healthcare | ||
UCB | €179.50 | -4.1% | 87.8% | €34.1b | €204.75 | PE141.9x | E28.4% | 0.8% | Pharmaceuticals & Biotech | ||
ANTO | UK£18.47 | 0.3% | 3.3% | UK£18.2b | UK£19.13 | PE27.8x | E15.3% | 1.3% | Materials | ||
MBLY | US$17.77 | 1.9% | -26.8% | US$14.7b | US$20.31 | PS8.7x | E106.6% | n/a | Automobiles | ||
GFS | US$44.55 | 4.0% | -17.7% | US$25.3b | US$47.81 | PS3.6x | E41.9% | n/a | Semiconductors | ||
ZG | US$75.45 | 0.07% | 47.2% | US$19.2b | US$87.83 | PS8.2x | E50.1% | n/a | Real Estate Management and Development |